MedTrace Logo

Comparison of Intraperitoneal Bupivacaine Alone or With Dexmedetomidine

NCT06560892 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2024-08-21

No results posted yet for this study

Summary

For patients with symptomatic cholelithiasis, laparoscopic cholecystectomy (LC) is a customary procedure for treatment these days. After LC, patients may experience considerable pain. This study was performed with the objective of comparing the mean duration of analgesia of intraperitoneal bupivacaine with dexmedetomidine to intraperitoneal bupivacaine alone in patients undergoing laparoscopic cholecystectomy.

Conditions

  • LAPAROSCOPIC CHOLECYSTECTOMY

Interventions

DRUG

Bupivacaine injection

patients received intraperitoneal bupivacaine 50 ml 0.25% + 5 ml normal saline.

DRUG

Dexmedetomidine injection

Patients were given intraperitoneal bupivacaine 50 ml 0.25% + dexmedetomidine 1 μg/kg with normal saline 5 ml.

Sponsors & Collaborators

  • Bahawal Victoria Hospital

    collaborator UNKNOWN

  • RESnTEC, Institute of Research

    lead OTHER

Principal Investigators

  • Qazi Anees, FCPS · Bahawal Victoria Hospital

  • Syed Shakeel Ahmed, FCPS · Shahida Islam Teaching Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-06-30
Completion
2024-06-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06560892 on ClinicalTrials.gov